New peer-reviewed research shows TikoMed’s ILB® mobilizes and modulates key growth factors that trigger a cascade of neuroprotective mechanisms able to target all neuroinflammation-driven diseases including Amyotrophic Lateral Sclerosis 31 August, 2022 Read More »